Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
doi 10.1155/2013/782903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology
MedicineHepatology
2017English

A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology
Cancer ResearchOncology
2019English

Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536

Haematologica
Hematology
2011English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy